<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=INSR</id>
	<title>INSR - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=INSR"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=INSR&amp;action=history"/>
	<updated>2026-04-08T02:59:25Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=INSR&amp;diff=4453&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Insulin receptor precursor (EC 2.7.10.1) (IR) (CD220 antigen) [Contains: Insulin receptor subunit alpha; Insulin receptor subunit beta]  ==Publications==  {{medli...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=INSR&amp;diff=4453&amp;oldid=prev"/>
		<updated>2021-04-29T19:18:58Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Insulin receptor precursor (EC 2.7.10.1) (IR) (CD220 antigen) [Contains: Insulin receptor subunit alpha; Insulin receptor subunit beta]  ==Publications==  {{medli...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Insulin receptor precursor (EC 2.7.10.1) (IR) (CD220 antigen) [Contains: Insulin receptor subunit alpha; Insulin receptor subunit beta]&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Proteomics of Long-Lived Mammals.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31737995&lt;br /&gt;
|abstract=Mammalian species differ up to 100-fold in their aging rates and maximum lifespans. Long-lived mammals appear to possess traits that extend lifespan and healthspan. Genomic analyses have not revealed a single pro-longevity function that would account for all longevity effects. In contrast, it appears that pro-longevity mechanisms may be complex traits afforded by connections between metabolism and protein functions that are impossible to predict by genomic approaches alone. Thus, metabolomics and proteomics studies will be required to understand the mechanisms of longevity. Several examples are reviewed that demonstrate the naked mole rat (NMR) shows unique proteomic signatures that contribute to longevity by overcoming several hallmarks of aging. [[SIRT6]] is also discussed as an example of a protein that evolves enhanced enzymatic function in long-lived species. Finally, it is shown that several longevity-related proteins such as Cip1/p21, [[FOXO3]], [[TOP2A]], [[AKT1]], [[RICTOR]], [[INSR]], and [[SIRT6]] harbor posttranslational modification (PTM) sites that preferentially appear in either short- or long-lived species and provide examples of crosstalk between PTM sites. Prospects of enhancing lifespan and healthspan of humans by altering metabolism and proteoforms with drugs that mimic changes observed in long-lived species are discussed.&lt;br /&gt;
&lt;br /&gt;
|keywords=* SIRT6&lt;br /&gt;
* aging&lt;br /&gt;
* long-lived mammals&lt;br /&gt;
* naked mole rats&lt;br /&gt;
* proteomics&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117992&lt;br /&gt;
}}&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=The Ubiquitin Ligase CHIP Integrates Proteostasis and Aging by Regulation of Insulin Receptor Turnover.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28431247&lt;br /&gt;
|abstract=Aging is attended by a progressive decline in protein homeostasis (proteostasis), aggravating the risk for protein aggregation diseases. To understand the coordination between proteome imbalance and longevity, we addressed the mechanistic role of the quality-control ubiquitin ligase CHIP, which is a key regulator of proteostasis. We observed that CHIP deficiency leads to increased levels of the insulin receptor ([[INSR]]) and reduced lifespan of worms and flies. The membrane-bound [[INSR]] regulates the insulin and [[IGF1]] signaling (IIS) pathway and thereby defines metabolism and aging. [[INSR]] is a direct target of CHIP, which triggers receptor monoubiquitylation and endocytic-lysosomal turnover to promote longevity. However, upon proteotoxic stress conditions and during aging, CHIP is recruited toward disposal of misfolded proteins, reducing its capacity to degrade the [[INSR]]. Our study indicates a competitive relationship between proteostasis and longevity regulation through CHIP-assisted proteolysis, providing a mechanistic concept for understanding the impact of proteome imbalance on aging.&lt;br /&gt;
|mesh-terms=* Aging&lt;br /&gt;
* Animals&lt;br /&gt;
* Antigens, CD&lt;br /&gt;
* Caenorhabditis elegans&lt;br /&gt;
* Drosophila melanogaster&lt;br /&gt;
* Endocytosis&lt;br /&gt;
* Humans&lt;br /&gt;
* Longevity&lt;br /&gt;
* Lysosomes&lt;br /&gt;
* Proteolysis&lt;br /&gt;
* Proteome&lt;br /&gt;
* Receptor, Insulin&lt;br /&gt;
* Signal Transduction&lt;br /&gt;
* Somatomedins&lt;br /&gt;
* Ubiquitin-Protein Ligases&lt;br /&gt;
* Ubiquitination&lt;br /&gt;
|keywords=* C. elegans&lt;br /&gt;
* CHIP&lt;br /&gt;
* DAF-2&lt;br /&gt;
* Drosophila&lt;br /&gt;
* aging&lt;br /&gt;
* chaperone&lt;br /&gt;
* insulin signaling&lt;br /&gt;
* longevity&lt;br /&gt;
* proteostasis&lt;br /&gt;
* ubiquitin&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406386&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>